SYNTi
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
SYNTi, a PDZ domain inhibitor, specifically targets the syndecan/syntenin protein-protein interaction, demonstrating an IC50 of 400 nM and a ligand efficiency (LE) value of 0.24. It holds potential for use in breast cancer research.
Smiles
CC(C1=CC=C(F)C(C2=CC=C(C[C@H](N3C(C4=CC=C(Br)C=C4C3)=O)C(N[C@@H](C)C(O)=O)=O)C=C2)=C1)=O
Molecular Formula
C28H24BrFN2O5
Molecular Weight
567.4
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
P1001-05S-APC 200 µL
P27Kip1, phosphorylated (Thr187) (Cyclin-dependent Kinase Inhibitor 1B, Cyclin-dependent Kinase Inhibitor p27, CDKN1B, KIP1) (APC) discontinued
Ask
View Details 